Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Costello Beth AnnEVP and CFO | Option exercise · 10b5-1 plan | M | $1.70M 31.6K sh |
| Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Reed David L.EVP & CFO | Tax withholding | F | $81K 345 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $150K 2,738 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Hart IlanChief Financial Officer | Tax withholding | F | $216K 24.4K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Kossover AmyChief Accounting Officer | Tax withholding | F | $61K 10.2K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Yi StevenDirector, See Remarks | Open-market sale · 10b5-1 plan | SELL | $1.96M 130.1K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $166K 408 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Nonko EugeneDirector | Open-market sale · 10b5-1 plan | SELL | $1.43M 93.3K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $213K 520 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Fesko JohnPRESIDENT, CHIEF BUS. OFFICER | Open-market sale · 10b5-1 plan | SELL | $118K 295 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Southern Cross Acquisition II Sponsor Corp.10% Owner | Other acquisition or disposition | J | — 324.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $172K 6,700 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $63K 1,129 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Brophy Michael BurkesCHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $184K 470 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Turner KamiChief Accounting Officer | Option exercise | M | $134K 7,600 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Lenkowsky AdamEVP, Chief Commercial Officer | Tax withholding | F | $237K 3,848 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $176K 432 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Swanson Luke RoyCHIEF TECHNOLOGY OFFICER | Open-market sale · 10b5-1 plan | SELL | $145K 2,363 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Coloma Jason VDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $799K 26.6K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Fain Richard DDirector | Gift | G | — 5,605 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Swanson Luke RoyCHIEF TECHNOLOGY OFFICER | Open-market sale · 10b5-1 plan | SELL | $185K 3,094 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Swanson Luke RoyCHIEF TECHNOLOGY OFFICER | Open-market sale · 10b5-1 plan | SELL | $212K 3,283 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Bidzos D JamesDirector, Exec. Chairman, Pres, & CEO | Open-market sale · 10b5-1 plan | SELL | $357K 1,160 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Vassil JonathanChief Revenue Officer | Open-market sale · 10b5-1 plan | SELL | $373K 11.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Daspit MarisaCHIEF PEOPLE OFFICER | Open-market sale · 10b5-1 plan | SELL | $36K 720 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | Baughman Michael JExec VP, CFO & CAO | Tax withholding | F | $740K 4,406 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | Ramnath VidyaSenior VP &CMO | Tax withholding | F | $304K 1,812 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | Baughman Michael JExec VP, CFO & CAO | Tax withholding | F | $333K 2,000 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 15 | Sorsby J LarryDirector | Tax withholding | F | $366K 3,491 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | Tsao DavidDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $125K 1,130 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | Tsao DavidDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $114K 1,063 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | Mitra SabyaschiGroup President | Tax withholding | F | $426K 2,536 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | Zornio PeterChief Technology Officer | Tax withholding | F | $499K 2,970 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | Atay OguzhanDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $105K 974 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | Raketich Kevin AEVP, Strategy & Corp. Dev. | Open-market sale · 10b5-1 plan | SELL | $24K 1,080 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | Williams Michael SDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $22K 985 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | Tkachenko IgorVP, Corporate Strategy | Grant or award | A | — 15.4K sh | Nov 4, 2026 traded Oct 30, 2026 |
| 15 | Ledingham DianneDirector | Open-market sale · 10b5-1 plan | SELL | $34K 1,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | Atay OguzhanDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $60K 536 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | Hovnanian Ara KDirector, Chairman of the Board & CEO, 10% Owner | Tax withholding | F | $458K 4,368 sh | Nov 4, 2026 traded Nov 2, 2026 |